Cresco Labs Inc. (CL.CN)
| Previous Close | 2.2500 |
| Open | 2.2400 |
| Bid | 2.2000 x 0 |
| Ask | 2.2500 x 0 |
| Day's Range | 2.2000 - 2.2600 |
| 52 Week Range | 1.4500 - 3.5800 |
| Volume | |
| Avg. Volume | 148,946 |
| Market Cap | 775.3M |
| Beta (5Y Monthly) | 1.97 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.6900 |
| Earnings Date | Nov 13, 2024 - Nov 18, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.47 |
Business WireCresco Labs Announces Dennis Olis to Retire as Chief Financial Officer
CHICAGO, September 12, 2024--Cresco Labs Announces Dennis Olis to Retire as Chief Financial Officer
- Yahoo Finance Video
Cannabis stocks rise after Trump backs legalization measure in Fla.
Cannabis stocks (CGC, TLRY, CURLF, CRLBF, GTBIF) are rising after former President Donald Trump announced he would vote in favor of Florida's ballot measure to legalize marijuana for recreational use. Market Domination Hosts Julie Hyman and Josh Lipton report more on the story and how cannabis stocks have performed this year so far. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Melanie Riehl
- Yahoo Finance Video
DEA sets date for marijuana rescheduling for after election
Drug Enforcement Administration (DEA) officials has set the date for a hearing to possibly reclassify marijuana to a Schedule 1 drug on December 2, after the 2024 presidential election. Cannabis stocks, including Curaleaf (CURLF), Tilray (TLRY), Green Thumb (GTBIF), Cresco Labs (CRLBF), and Verano Holdings (VRNOF), are sliding on this news. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Luke Carberry Mogan.
